A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview. - Wikidata - wikimedia - TriplyDB

A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.

A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.

http://www.wikidata.org/entity/Q37428436

about

Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration Adverse effects of biologics: a network meta-analysis and Cochrane overview Adverse effects of biologics: a network meta-analysis and Cochrane overview Efficacy and safety of biological agents for systemic juvenile idiopathic arthritis: a systematic review and meta-analysis of randomized trials Rate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: a systematic review and meta-analysis of drug registries and health care databases Recent insights into the role of autophagy in the pathogenesis of rheumatoid arthritis Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis Advances in the treatment of rheumatoid arthritis.Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analy Identification of S100A9 as biomarker of responsiveness to the methotrexate/etanercept combination in rheumatoid arthritis using a proteomic approach Effect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trials Comparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression Analysis Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritis Biological drugs for the treatment of rheumatoid arthritis by the subcutaneous route: interpreting efficacy data to assess statistical equivalence.Random-effects meta-analysis for systematic reviews of phase I clinical trials: Rare events and missing data.Comparative efficacy of biological agents in methotrexate-refractory rheumatoid arthritis patients: a Bayesian mixed treatment comparison.Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis.[The safety of biologics : a risk-benefit assessment of treating rheumatoid arthritis with biologics based on registry data on mortality].Smoking and outcomes after knee and hip arthroplasty: a systematic review Cross-cultural validation of the Educational Needs Assessment Tool in RA in 7 European countries.Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials.Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trials Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial Graphical tools for network meta-analysis in STATA.Infliximab: 12 years of experience The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial.Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective.Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial.The impact of steroids, methotrexate, and biologics on clinical and radiographic outcomes in patients with rheumatoid arthritis undergoing fusions at the craniovertebral junction.Application of a validated algorithm to estimate the effectiveness and cost of biologics for rheumatoid arthritis in the US pharmacy benefit manager context.Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy.Most Trial Eligibility Criteria and Patient Baseline Characteristics Do Not Modify Treatment Effect in Trials Using Targeted Therapies for Rheumatoid Arthritis: A Meta-Epidemiological Study.Safety and effectiveness responses to etanercept for rheumatoid arthritis in Japan: a sub-analysis of a post-marketing surveillance study focusing on the duration of rheumatoid arthritis.Drug usage analysis and health care resources consumption in naïve patients with rheumatoid arthritis.Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective Use of biologics in a patient with rheumatoid arthritis refractory to methotrexate.A five-year model to assess the early cost-effectiveness of new diagnostic tests in the early diagnosis of rheumatoid arthritis Patient Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: Findings from a Patient Survey in Europe.

P2860

Q24193614-87CCA9BD-995C-4033-A76B-9B3AC42BDB73 Q24234197-5A57B5C7-5E9D-45FE-88B8-9E2BE6871574 Q24235218-C1A6A94E-356D-467C-B0B4-9FA4CCD01A69 Q26775512-10C63772-5A88-409C-BD57-7CDDD118ECBC Q26778600-96A2B928-030B-4CBB-BE86-9B1FFD0B611F Q26784021-44C5DE00-7ECD-413F-870B-FA4456752A70 Q26852081-43F88F3A-98F8-48A3-9EB9-68F67E8C045B Q27691822-FB165859-0444-4092-B69A-B5C44DC4A225 Q27694496-48435D13-058E-47A2-A32D-6E8C5AC84B0B Q28542901-E1D1941C-6460-443F-8457-E7063D742683 Q28543128-1F7D4614-2AEF-48E6-A46C-BA70934EE016 Q28547851-171D4F3E-282B-43A3-8974-D1E3E245DF57 Q30832987-BB2E0F8A-27D5-4400-968E-691963AC22F2 Q30872562-4D43132B-22FA-46BD-BABD-2D12BAE7C7AE Q31107166-7CFD4D94-A0E6-4DBB-A228-FD6A535037E2 Q33690668-2CBFF6F1-AE8C-4D27-8BC2-10715004B5B9 Q33730446-7328D201-D407-4923-B9EA-9BDC19AE890F Q33743130-55D0E975-8754-4B3E-A2FE-43E07CA79952 Q33776622-3EE28F5C-8ACC-489E-9C6D-451DF429DF13 Q33910506-55BAFC06-A1AB-4E5A-92EA-2CE1D11897C1 Q34327978-E605716F-126D-4B2F-BD72-080ED4960A6D Q34563933-FE042C40-1E4A-44E0-9819-66C4380B06D8 Q34767921-9040C1DA-A4E7-41E7-B6A3-618FAC157795 Q35009612-ED179979-E882-4EB3-AC61-FC22E9D2789B Q35070446-5989EFB8-B8E4-4291-9278-A60982276AC7 Q35082559-68AF3847-A8C4-4996-9021-94EE733F12E8 Q35174817-1C2948B0-1214-43E2-992A-5F94AD85215E Q35237588-79446E7C-5162-4364-8A2D-8DD3D59ABCC4 Q35348182-F64B6E12-A9DF-44C4-9D18-706FD18958B5 Q35590542-657B332E-F6BF-4B0A-882A-B41DD3E9EDCD Q35617540-21E3E543-62AB-47A3-A52D-806A1E30FF4F Q35620336-B1081D24-FDE3-49A0-A39C-351359B2908C Q35636624-61061610-3F87-4797-8097-76FC181C9BC9 Q35770656-3A6F022C-2189-48CD-A6D6-D9F53F8A2D6E Q35999139-D10240B1-8DAD-4891-9059-5CFB38DF8631 Q36274355-86258ACC-BADE-4E68-A722-EC6C98E5598C Q36439036-222FA4FD-3497-43C9-8031-FC6E21BFC4B4 Q36923376-EB8B7470-5117-4D24-B6EF-3F549DA7945B Q36994587-3705937B-D7A8-46CD-B380-D5782851F34F Q37453045-ECC02B87-76A0-4588-9B6E-87EC6966A8E4

P2860

A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.

http://www.wikidata.org/entity/Q37428436

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

A network meta-analysis of ran ...... rthritis: a Cochrane overview.

@en

A network meta-analysis of ran ...... rthritis: a Cochrane overview.

@nl

type

label

A network meta-analysis of ran ...... rthritis: a Cochrane overview.

@en

A network meta-analysis of ran ...... rthritis: a Cochrane overview.

@nl

prefLabel

A network meta-analysis of ran ...... rthritis: a Cochrane overview.

@en

A network meta-analysis of ran ...... rthritis: a Cochrane overview.

@nl

P1433

Q37428436-DF77CBC2-B58E-4E7A-A699-0875258F733B

P1476

Q37428436-8FAAC1C2-3569-4860-835C-4D29DEEA087F

P2093

Q37428436-1EECC3DD-2106-41D6-A19D-57E5D63CC070

Q37428436-52AD3810-857A-46E5-8CA7-9D8F491361BF

Q37428436-5C9D45BC-21E1-4602-854E-CF52EB0CAE1D

Q37428436-7C6AE863-69B3-429A-8FF4-715E18218BF9

P2860

Q37428436-02574010-EC3E-4CFC-95D9-3FC5BDEB80FF

Q37428436-0548EFC6-DB18-470B-BD34-9755336797AC

Q37428436-0F226DBC-172C-41B2-880E-D7D4DCC01F9C

Q37428436-12E73B8C-DFF6-4EA3-BACB-E8EB3724D5FC

Q37428436-2D35AF54-8F9E-4A46-8283-C969FA4773A7

Q37428436-33B04680-E7E0-4DFD-8FEF-D316C9FB203A

Q37428436-33DAF5D3-93F5-4034-8BDE-27033C9ABEA8

Q37428436-3C1BD89E-79DA-4007-B8B1-E690E7919A15

Q37428436-45163A8C-8F2B-4825-B4A4-13076EF62ABD

Q37428436-45F1BF60-345F-42F3-A787-0A1730F4B7DD

P304

Q37428436-3FFB6A63-66C9-4FE4-BA60-A00E77F703BE

P31

Q37428436-08F1230A-C9FA-4DD6-8880-0128E155A901

Q37428436-46116683-c607-4b0d-9ee3-09997249c8fa

P356

Q37428436-8A89E6F3-65D9-469B-B4AD-2001C89ADD87

P407

Q37428436-6B36E767-BF84-44DF-A4C5-775088A4BC01

P433

Q37428436-EBEB2E3D-AE0F-47D7-9319-D05618433153

P478

Q37428436-E4018B1B-DD85-4ABE-A2D2-7BB4BCC304B4

P50

Q37428436-09512A36-15C4-43DF-B7F6-38D6E2AC5FAE

Q37428436-13D2B57C-300B-44E7-B72A-EF01D762402E

Q37428436-78B8B779-C350-4C15-89B8-E74E8E72A2EF

Q37428436-89328BCF-58DA-4FE7-88FB-E49E685E48E3

P577

Q37428436-A411BFBF-B67B-4CA6-8F9D-83E1722D32BE

P5875

Q37428436-35A72DD1-E48A-4FC3-9CA3-CAB8E2512D91

P698

Q37428436-1B945D6D-6489-4908-9DF3-2934129022FF

P921

Q37428436-CBB64427-B31C-470B-8B54-DE16697A44DF

P932

Q37428436-E5578F97-A300-4AFE-85E3-7AE850BB9BE8

P356

P1433

Canadian Medical Association Journal

P1476

A network meta-analysis of ran ...... rthritis: a Cochrane overview.

@en

P2093

Elizabeth Tanjong Ghogomu

http://www.w3.org/2001/XMLSchema#string

George A Wells

http://www.w3.org/2001/XMLSchema#string

Maria E Suarez-Almazor

http://www.w3.org/2001/XMLSchema#string

Robin Christensen

http://www.w3.org/2001/XMLSchema#string

P2860

Rituximab for rheumatoid arthritis

Abatacept for rheumatoid arthritis

Biologics for rheumatoid arthritis: an overview of Cochrane reviews

Anakinra for rheumatoid arthritis

Adalimumab for treating rheumatoid arthritis

Etanercept for the treatment of rheumatoid arthritis

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

P304

787-796

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1503/CMAJ.091391

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

181

http://www.w3.org/2001/XMLSchema#string

P50

Rachelle Buchbinder

Jasvinder A. Singh

Maria Angeles Lopez-Olivo

P577

2009-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38062395

http://www.w3.org/2001/XMLSchema#string

P698

19884297

http://www.w3.org/2001/XMLSchema#string

P921

P932

2780484

http://www.w3.org/2001/XMLSchema#string